NLS Pharmaceutics Valuation
| NLSPW Stock | USD 0.02 0 6.67% |
NLS Pharmaceutics seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of NLS Pharmaceutics from inspecting the firm fundamentals such as Number Of Shares Shorted of 3.52 K, return on asset of -1.11, and EBITDA of (3.63 M) as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NLS Pharmaceutics' price fluctuation is out of control at this time. Calculation of the real value of NLS Pharmaceutics is based on 3 months time horizon. Increasing NLS Pharmaceutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NLS stock is determined by what a typical buyer is willing to pay for full or partial control of NLS Pharmaceutics AG. Since NLS Pharmaceutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NLS Stock. However, NLS Pharmaceutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.016 | Real 0.0138 | Hype 0.0139 | Naive 0.0153 |
The intrinsic value of NLS Pharmaceutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NLS Pharmaceutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NLS Pharmaceutics AG helps investors to forecast how NLS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NLS Pharmaceutics more accurately as focusing exclusively on NLS Pharmaceutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NLS Pharmaceutics' intrinsic value based on its ongoing forecasts of NLS Pharmaceutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NLS Pharmaceutics' closest peers.
NLS Pharmaceutics Cash |
|
NLS Valuation Trend
Analysing the historical paterns of NLS Pharmaceutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of NLS Pharmaceutics AG over time and is usually enough for investors to make rational market timing decisions.
NLS Pharmaceutics Total Value Analysis
NLS Pharmaceutics AG is now projected to have takeover price of 0 with market capitalization of 37.77 M, debt of 826.76 K, and cash on hands of 145.4 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the NLS Pharmaceutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 37.77 M | 826.76 K | 145.4 K |
NLS Pharmaceutics Asset Utilization
One of the ways to look at asset utilization of NLS is to check how much profit was generated for every dollar of assets it reports. NLS Pharmaceutics AG secures a negative usage of assets of -1.11 %, losing $0.0111 for each dollar of assets held by the firm. Unsuccessful asset utilization conveys that the company is being less competent with each dollar of assets it secures. Strictly speaking, asset utilization of NLS Pharmaceutics AG shows how unproductive it operates for each dollar spent on its assets.NLS Pharmaceutics Profitability Analysis
Net Loss for the year was (1.98 M) with profit before overhead, payroll, taxes, and interest of 0.About NLS Pharmaceutics Valuation
Our relative valuation model uses a comparative analysis of NLS Pharmaceutics. We calculate exposure to NLS Pharmaceutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NLS Pharmaceutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -10.3 K | -10.8 K |
NLS Pharmaceutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as NLS Pharmaceutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.8 M |
NLS Pharmaceutics Current Valuation Indicators
Valuation refers to the process of determining the present value of NLS Pharmaceutics AG and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NLS we look at many different elements of the entity such as NLS's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NLS Pharmaceutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NLS Pharmaceutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NLS Pharmaceutics' worth.Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.